ACCORD: Bursaries for patient and public involvement in research
MHRA suspends use of certain Gadolinium contrast agents (GdCAs), and restricts uses of others.
A class 2 medicine recall – action within 48 hours – has now been issued by the MHRA for Magnevist (Bayer plc) and Omniscan Solution (GE Healthcare).
Changes to IRAS from 18 October 2017
Changes to IRAS - Effective June 28th 2017
The eHealth IT Security policy is available here: http://www.accord.scot/researcher-access/ehealth-it-security-policy
Statement from the MHRA on inspections of Labs analysing human samples as part of a clinical trial.
The 2016 Accord brochure can be found HERE
Management of Deviations & Violations Training Materials available.
New HRA Approval documents are available
CSO Research Strategy launched October 2015.
The HRA have developed six new eLearning modules as an aid for researchers, R&D staff, study sponsors, research ethics committee members and the wider research community.
Please update your recruitment figures regularly
Integrated Addendum to ICH E6(R1): Guideline for Good Clinical Practice E6(R2)
Downtime notice for EudraCT Results & New Release of EudraCT 10.4.0.0.
Essential computer maintenance affecting EudraCT on 12/13 October 2017
Find out about ACCORD
Get involved in research
Advice and resources
Collaborate with us